Madrigal Pharmaceuticals adopts 2026 Stock Plan for employee equity grants

Madrigal Pharmaceuticals, Inc. has adopted a new 2026 Stock Plan to grant equity awards including stock options, restricted stock, and cash-based awards to officers, employees, directors and consultants. The plan is designed to align employee interests with shareholder value creation and improve talent retention in the competitive pharmaceutical industry.